Wednesday, June 7, 2017

WHO new classification of ATB

Reuters Health News - June 07, 2017
"The World Health Organization published a new classification of antibiotics on Tuesday that aims to fight drug resistance, with penicillin–type drugs recommended as the first line of defense and others only for use when absolutely necessary.The new "essential medicines list" includes 39 antibiotics for 21 common syndromes, categorized into three groups: "Access," "Watch" and "Reserve."Drugs on the "Access" list have lower resistance potential and include the widely–used amoxicillin.The "Watch" list includes ciprofloxacin, which is commonly prescribed for cystitis and strep throat but "not that effective," WHO Assistant Director–General for Health Systems and Innovation Marie–Paule Kieny told reporters.Its use should be "dramatically reduced," the WHO said."We think that the political will is there but this needs to be followed by strong policies," Kieny said.In the "Reserve" category antibiotics such as colistin should be seen as a last resort. That prompts questions about how producers of such antibiotics could make money, said Suzanne Hill, WHO's Director of Essential Medicines and Health Products."What we need to do is stop paying for antibiotics based on how many times they are prescribed, to discourage use. We don't want colistin used very frequently. In fact we don't want it used at all," Hill said."What we need to do as a global community is work out how we pay the company not to market colistin and not to promote it and to keep it in reserve..."